Patents by Inventor Zimeng Wang

Zimeng Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING
    Publication number: 20240197642
    Abstract: This invention provides polymeric nanoparticles presenting non-conjugated BBB-crossing ligands on their surfaces, compositions and methods of use thereof, as well as non-conjugation methods to produce nanoparticles having BBB-crossing agents on their surfaces.
    Type: Application
    Filed: August 28, 2023
    Publication date: June 20, 2024
    Inventors: Bin Wu, Nicholas J. Boylan, Zimeng Wang, Jienu Xu
  • NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING
    Publication number: 20220175690
    Abstract: This invention provides polymeric nanoparticles presenting non-conjugated BBB-crossing ligands on their surfaces, compositions and methods of use thereof, as well as non-conjugation methods to produce nanoparticles having BBB-crossing agents on their surfaces.
    Type: Application
    Filed: November 16, 2021
    Publication date: June 9, 2022
    Inventors: Bin Wu, Nicholas Boylan, Zimeng Wang, Jieni Xu
  • NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING
    Publication number: 20220175689
    Abstract: This invention provides polymeric nanoparticles presenting non-conjugated BBB-crossing ligands on their surfaces, compositions and methods of use thereof, as well as non-conjugation methods to produce nanoparticles having BBB-crossing agents on their surfaces.
    Type: Application
    Filed: November 16, 2021
    Publication date: June 9, 2022
    Inventors: Bin Wu, Nicholas Boylan, Zimeng Wang, Jieni XU
  • PHARMACEUTICAL COMPOSITION OF SIGLEC-BINDING AGENTS
    Publication number: 20220142935
    Abstract: This invention provides a pharmaceutical composition comprising an agent that can bind Siglec receptors on cell surface. This invention also provides the method of preparing said pharmaceutical composition and the use thereof.
    Type: Application
    Filed: October 5, 2021
    Publication date: May 12, 2022
    Inventors: Bin Wu, Zimeng Wang, Nicholas Boylan, Jieni Xu